Total Funding
35
65
Total FundingSeed raised
Growth Score
-2 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
138716
DxDiscovery is a biotechnology research and development firm.
- David AuCoin: Co-Founder
- Thomas Kozel: Co-Founder and Chief Executive Officer
About the Company
DxDiscovery is a research and development company for biotechnology. The creation of moderate, microbial monoclonal antibody antibodies is the corporate objective. These antibodies may be created as preventatives or treatments for infectious diseases, or they may be used in quick POC diagnostics. Products in their diagnostics portfolio will help in
circumstances when the existing treatment protocol is time-consuming or very likely to yield erroneous results.
